Trial Profile
A Human Phase 0, Microdose Drug-Drug Interaction Study With [14C]-GSK706769 and Ketoconazole in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 706769 (Primary) ; Ketoconazole
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GSK
- 02 Feb 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2009 New trial record